(CNP) CenterPoint Energy - Ratings and Ratios
Electricity, Natural Gas, Transmission, Distribution, Energy
CNP EPS (Earnings per Share)
CNP Revenue
Description: CNP CenterPoint Energy
CenterPoint Energy Inc (NYSE:CNP) is a multi-utility holding company operating in the United States, primarily in the electric and natural gas sectors. The companys Electric segment provides transmission and distribution services, while the Natural Gas segment engages in intrastate natural gas sales, transportation, and distribution to various customers across several states.
Key performance indicators (KPIs) for CenterPoint Energy include the number of metered customers, which stood at approximately 2.82 million as of December 31, 2024. The company also owns 352 substations with a transformer capacity of 80,659 megavolt amperes, indicating significant infrastructure investment. Additionally, the companys natural gas operations are supported by around 219 miles of intrastate pipeline in Louisiana and Texas.
From a financial perspective, CenterPoint Energys market capitalization is substantial, standing at around $23.59 billion USD. The companys return on equity (RoE) is 9.09%, indicating a moderate level of profitability. The price-to-earnings (P/E) ratio is 24.42, with a forward P/E of 20.66, suggesting that the stock may be fairly valued relative to its earnings growth prospects.
To further evaluate CenterPoint Energys performance, other relevant KPIs could include revenue growth, earnings per share (EPS) growth, dividend yield, and debt-to-equity ratio. These metrics can provide insights into the companys ability to generate returns for shareholders, its financial leverage, and its overall financial health.
CNP Stock Overview
Market Cap in USD | 24,613m |
Sub-Industry | Multi-Utilities |
IPO / Inception | 1970-01-02 |
CNP Stock Ratings
Growth Rating | 87.2% |
Fundamental | 38.7% |
Dividend Rating | 59.1% |
Return 12m vs S&P 500 | 22.1% |
Analyst Rating | 3.53 of 5 |
CNP Dividends
Dividend Yield 12m | 2.43% |
Yield on Cost 5y | 4.93% |
Annual Growth 5y | 1.82% |
Payout Consistency | 94.9% |
Payout Ratio | 56.9% |
CNP Growth Ratios
Growth Correlation 3m | 68.7% |
Growth Correlation 12m | 94.1% |
Growth Correlation 5y | 83% |
CAGR 5y | 16.49% |
CAGR/Max DD 5y | 0.72 |
Sharpe Ratio 12m | 1.72 |
Alpha | 33.87 |
Beta | 0.318 |
Volatility | 18.26% |
Current Volume | 4846.9k |
Average Volume 20d | 4053.6k |
Stop Loss | 36.5 (-3.2%) |
Signal | 0.85 |
Piotroski VR‑10 (Strict, 0-10) 3.0
Net Income (936.0m TTM) > 0 and > 6% of Revenue (6% = 538.9m TTM) |
FCFTA -0.05 (>2.0%) and ΔFCFTA -4.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -8.52% (prev 7.82%; Δ -16.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.05 (>3.0%) and CFO 2.00b > Net Income 936.0m (YES >=105%, WARN >=100%) |
Net Debt (21.52b) to EBITDA (3.43b) ratio: 6.28 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.79 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (654.0m) change vs 12m ago 1.87% (target <= -2.0% for YES) |
Gross Margin 44.00% (prev 46.06%; Δ -2.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 21.12% (prev 20.91%; Δ 0.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 2.36 (EBITDA TTM 3.43b / Interest Expense TTM 850.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.41
(A) -0.02 = (Total Current Assets 2.93b - Total Current Liabilities 3.69b) / Total Assets 44.10b |
(B) 0.04 = Retained Earnings (Balance) 1.92b / Total Assets 44.10b |
(C) 0.05 = EBIT TTM 2.01b / Avg Total Assets 42.54b |
(D) 0.06 = Book Value of Equity 1.91b / Total Liabilities 33.08b |
Total Rating: 0.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 38.69
1. Piotroski 3.0pt = -2.0 |
2. FCF Yield -5.15% = -2.57 |
3. FCF Margin -26.43% = -7.50 |
4. Debt/Equity 1.96 = 0.83 |
5. Debt/Ebitda 6.30 = -2.50 |
6. ROIC - WACC 1.09% = 1.36 |
7. RoE 8.67% = 0.72 |
8. Rev. Trend -2.36% = -0.12 |
9. Rev. CAGR 0.78% = 0.10 |
10. EPS Trend 24.43% = 0.61 |
11. EPS CAGR -1.90% = -0.24 |
What is the price of CNP shares?
Over the past week, the price has changed by -0.89%, over one month by -0.95%, over three months by +2.20% and over the past year by +42.77%.
Is CenterPoint Energy a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNP is around 42.68 USD . This means that CNP is currently undervalued and has a potential upside of +13.18% (Margin of Safety).
Is CNP a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 12
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CNP price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 40.4 | 7% |
Analysts Target Price | 40.4 | 7% |
ValueRay Target Price | 45.8 | 21.3% |
Last update: 2025-08-26 04:34
CNP Fundamental Data Overview
CCE Cash And Equivalents = 93.0m USD (last quarter)
P/E Trailing = 26.3636
P/E Forward = 21.7391
P/S = 2.7403
P/B = 2.2544
P/EG = 2.4906
Beta = 0.572
Revenue TTM = 8.98b USD
EBIT TTM = 2.01b USD
EBITDA TTM = 3.43b USD
Long Term Debt = 20.56b USD (from longTermDebt, last quarter)
Short Term Debt = 1.05b USD (from shortTermDebt, last quarter)
Debt = 21.62b USD (Calculated: Short Term 1.05b + Long Term 20.56b)
Net Debt = 21.52b USD (from netDebt column, last quarter)
Enterprise Value = 46.14b USD (24.61b + Debt 21.62b - CCE 93.0m)
Interest Coverage Ratio = 2.36 (Ebit TTM 2.01b / Interest Expense TTM 850.0m)
FCF Yield = -5.15% (FCF TTM -2.37b / Enterprise Value 46.14b)
FCF Margin = -26.43% (FCF TTM -2.37b / Revenue TTM 8.98b)
Net Margin = 10.42% (Net Income TTM 936.0m / Revenue TTM 8.98b)
Gross Margin = 44.00% ((Revenue TTM 8.98b - Cost of Revenue TTM 5.03b) / Revenue TTM)
Tobins Q-Ratio = 24.13 (Enterprise Value 46.14b / Book Value Of Equity 1.91b)
Interest Expense / Debt = 0.90% (Interest Expense 195.0m / Debt 21.62b)
Taxrate = 16.06% (from yearly Income Tax Expense: 195.0m / 1.21b)
NOPAT = 1.68b (EBIT 2.01b * (1 - 16.06%))
Current Ratio = 0.79 (Total Current Assets 2.93b / Total Current Liabilities 3.69b)
Debt / Equity = 1.96 (Debt 21.62b / last Quarter total Stockholder Equity 11.02b)
Debt / EBITDA = 6.30 (Net Debt 21.52b / EBITDA 3.43b)
Debt / FCF = -9.11 (Debt 21.62b / FCF TTM -2.37b)
Total Stockholder Equity = 10.79b (last 4 quarters mean)
RoA = 2.12% (Net Income 936.0m, Total Assets 44.10b )
RoE = 8.67% (Net Income TTM 936.0m / Total Stockholder Equity 10.79b)
RoCE = 6.40% (Ebit 2.01b / (Equity 10.79b + L.T.Debt 20.56b))
RoIC = 5.27% (NOPAT 1.68b / Invested Capital 31.95b)
WACC = 4.18% (E(24.61b)/V(46.23b) * Re(7.19%)) + (D(21.62b)/V(46.23b) * Rd(0.90%) * (1-Tc(0.16)))
Shares Correlation 5-Years: 100.0 | Cagr: 1.80%
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -2.37b)
Revenue Correlation: -2.36 | Revenue CAGR: 0.78%
Rev Growth-of-Growth: 10.43
EPS Correlation: 24.43 | EPS CAGR: -1.90%
EPS Growth-of-Growth: -32.06
Additional Sources for CNP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle